AMGEN INC (AMGN)
Clinical trial NCT06593522 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2030-11-29 → 2026-11-30 3. primary completion date: 2028-11-29 → 2026-10-31 4. enrollment: not set → 61 participants
Clinical trial NCT06593522 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2030-11-29 → 2026-11-30 3. primary completion date: 2028-11-29 → 2026-10-31 4. enrollment: not set → 61 participants
📉 **NEGATIVE** • Medium confidence analysis (63%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical